Actively Recruiting

Age: 18Years +
MALE
NCT06536725

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

Led by Tianjin Medical University Second Hospital · Updated on 2024-08-05

35

Participants Needed

2

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This project plans to establish an organoid chip model of prostate cancer patients with internal organ metastasis from surgical or biopsy tissue sources, and test the sensitivity of commonly used chemotherapy drugs based on organoid chip drug sensitivity testing technology to screen out sensitive individualized treatment plans.

CONDITIONS

Official Title

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with visceral metastasis of prostate cancer diagnosed clinically or pathologically
  • Age 18 years or older
  • ECOG score 2 or less, or a score of 3-4 due to tumor progression
  • Normal liver and kidney function with specific lab values within normal ranges
  • Normal bone marrow function with neutrophil count of at least 1800/mm3 and platelet count of at least 100000/mm3
  • Able to provide surgical or biopsy tissue samples
  • Willing to participate and sign informed consent
Not Eligible

You will not qualify if you...

  • Severe heart, liver, kidney, or peripheral nervous system diseases
  • Autoimmune diseases such as hyperthyroidism, hypothyroidism, or systemic lupus erythematosus
  • Unable to obtain tissue samples
  • Active pulmonary tuberculosis
  • Preparing for or having had tissue or organ transplants
  • Any other conditions deemed unsuitable by researchers for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Tianjin Medical Unversity Second Hospital

Tianjin, Tianjin Municipality, China, 300211

Actively Recruiting

2

Tianjin Medical Unversity Second Hospital

Tianjin, Tianjin Municipality, China

Actively Recruiting

Loading map...

Research Team

H

Haitao Wang, Ph.D

CONTACT

J

Jinhuan Wang, Ph.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here